| Literature DB >> 27697611 |
Jia You1, Jia Liu1, Yantao Bao1, Liqun Wang1, Yang Yu2, Lei Wang3, Di Wu1, Chang Liu1, Nan Wang1, Fei Wang1, Falin Wang1, Lu Xu1, Xing Tian1, Hongbin Liang1, Yating Gao1, Rongwei Guan1, Jing Bai1, Xiangning Meng1, Wenjing Sun1, Xin-Yuan Guan4, Chunyu Zhang5, Songbin Fu6, Yan Jin7.
Abstract
Previous studies have shown that the oncogene SEI1 is highly expressed in ovarian carcinomas, and promoting genomic instability. However, the molecular mechanism of SEI1 in promoting genomic instability remains unclear. We observed SEI1 overexpression in 30 of 46 cases of ovarian cancer compared to non-tumor tissues and the overexpression of SEI1 was positively associated with the tumor FIGO stage. Our functional studies revealed that overexpression of SEI1 could induce genomic instability and increased DNA strand breaks. In contrast, SEI1 co-localized with γH2AX and phosphorylated ATM and DNAPKcs in the nucleus. Furthermore, we found that overexpression of SEI1 induced translocation of the SEI1 protein from the cytoplasm to the nucleus; ATM and DNAPKcs were associated with the cytoplasm-to-nucleus translocation of SEI1. To further prove the correlation between the DNA damage response (DDR) and SEI1, we knocked down SEI1 expression in SEI1-transfected ovarian cancer cell lines. The expression of DDR proteins was significantly downregulated, and the number of micronuclei was significantly decreased. Together, these results define a new mechanism of SEI1 in the regulation of genomic stability and in the malignant progression of ovarian cancer. Copyright ÂEntities:
Keywords: DDR; Genomic instability; Ovarian cancer; SEI1; SERTAD1
Mesh:
Substances:
Year: 2016 PMID: 27697611 DOI: 10.1016/j.canlet.2016.09.032
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679